Profil
M.
David MacFarlane worked as an Independent Director at Titan Pharmaceuticals, Inc. from 2011 to 2023.
Prior to that, he was the Vice President of Regulatory Affairs at Genentech, Inc. from 1989 to 1999.
He also held the same position at Glaxo, Inc.
Anciens postes connus de M. MacFarlane
| Sociétés | Poste | Fin |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Director/Board Member | 29/06/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 01/08/1999 |
| Glaxo, Inc. | General Counsel | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Glaxo, Inc. |
